←Back to Expert Scholars
Translational Medicine / 转化医学KRAS G12C Later-Line Therapy
Marwan Fakih
MD
🏢City of Hope🌐USA
Professor, Department of Medical Oncology
55
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Marwan Fakih has been a key investigator in KRAS G12C inhibitor trials for both NSCLC and colorectal cancer. His research addresses later-line treatment strategies and combination approaches to improve KRAS inhibitor efficacy. He has contributed to understanding differential KRAS G12C inhibitor activity across tumor types.
Share:
🧪Research Fields 研究领域
KRAS G12C
Sotorasib
Colorectal cancer
NSCLC later lines
Combination therapy
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Marwan Fakih 的研究动态
Follow Marwan Fakih's research updates
留下邮箱，当我们发布与 Marwan Fakih（City of Hope）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment